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The Diversity of Bioactive Proteins in
Australian Snake Venoms*□S
Geoff W. Birrell‡§¶, Stephen T. H. Earl‡§¶, Tristan P. Wallis‡**, Paul P. Masci‡‡,
John de Jersey§§, Jeffrey J. Gorman‡**, and Martin F. Lavin‡§¶¶
Australian elapid snakes are among the most venomous
in the world. Their venoms contain multiple components
that target blood hemostasis, neuromuscular signaling,
and the cardiovascular system. We describe here a com-
prehensive approach to separation and identification of
the venom proteins from 18 of these snake species, rep-
resenting nine genera. The venom protein components
were separated by two-dimensional PAGE and identified
using mass spectrometry and de novo peptide sequencing.
The venoms are complex mixtures showing up to 200 pro-
tein spots varying in size from <7 to over 150 kDa and in pI
from 3 to >10. These include many proteins identified pre-
viously in Australian snake venoms, homologs identified in
other snake species, and some novel proteins. In many
cases multiple trains of spots were typically observed in the
higher molecular mass range (>20 kDa) (indicative of post-
translational modification). Venom proteins and their post-
translational modifications were characterized using spe-
cific antibodies, phosphoprotein- and glycoprotein-specific
stains, enzymatic digestion, lectin binding, and antivenom
reactivity. In the lower molecular weight range, several pro-
teins were identified, but the predominant species were
phospholipase A2 and -neurotoxins, both represented by
different sequence variants. The higher molecular weight
range contained proteases, nucleotidases, oxidases, and
homologs of mammalian coagulation factors. This informa-
tion together with the identification of several novel proteins
(metalloproteinases, vespryns, phospholipase A2 inhibitors,
protein-disulfide isomerase, 5-nucleotidases, cysteine-
rich secreted proteins, C-type lectins, and acetylcholines-
terases) aids in understanding the lethal mechanisms of
elapid snake venoms and represents a valuable resource
for future development of novel human therapeutics.
Molecular & Cellular Proteomics 6:973–986, 2007.
The venomous land snakes of Australia belong to the Elap-
idae family that also includes the Afro-Asian cobras, the
American coral snakes, the Asian kraits, and the African mam-
bas (1). The venoms are complex mixtures of proteins and
peptides possessing a variety of biological activities, and
because the amount of venom injected into an animal that
reaches the bloodstream may be minute, venom components
must achieve their effects at very low concentrations. The use
of snake venom in different pathophysiological conditions has
been mentioned in homeopathy and folk medicine for centu-
ries. Recently there have been a number of examples of snake
venoms used in the development of novel human therapeu-
tics. These include the antihypertensive drug captopril (2),
modeled from the venom of the Brazilian arrowhead viper
(Bothrops jaracusa); the anticoagulant Integrilin (eptifibatide
(3)), a heptapeptide derived from a protein found in the venom
of the American southeastern pygmy rattlesnake (Sistrurus
miliarius barbouri); Ancrod (4), a compound isolated from the
venom of the Malaysian pit viper (Agkistrodon rhodostoma) for
use in the treatment of heparin-induced thrombocytopenia
and stroke; and alfimeprase, a novel fibrinolytic metallopro-
teinase for thrombolysis derived from southern copperhead
snake (Agkistrodon contortrix contortrix) venom (5). Two
venom proteins from the Australian brown snake, Pseudonaja
textilis, are currently in development as human therapeutics
(QRxPharma). The first is a single agent procoagulant that is a
homolog of mammalian Factor Xa prothrombin activator (6),
whereas the other is a plasmin inhibitor, named Textilinin-1,
with antihemorrhagic properties (7).
Although there is much known about the protein composi-
tions of venoms from Asian and American snakes, compara-
tively little is known of Australian snakes. This is despite the
top 10 most toxic snakes (determined by LD50 (lethal dose in
mice to kill 50%)) being Australian elapid snakes (8). Austra-
lian snakes are most closely related to Asian snakes, and
although they have significantly higher toxicity, they cause far
fewer deaths by envenomation than their Asian counterparts,
most likely due to lower population density and more wide-
spread availability of suitable health care in Australia (8). Pro-
teins and peptides comprise the majority of the dry weight of
elapid snake venoms, whereas other components include
metallic cations, carbohydrates, nucleosides, biogenic
amines, and low levels of free amino acids and lipids (9, 10).
Venoms from Australian elapids can be loosely divided into
procoagulant and anticoagulant types. The procoagulant ven-
oms contain serine proteases (prothrombin activators) that
cleave prothrombin to produce thrombin in the coagulation
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cascade resulting in coagulation. Snake venom prothrombin
activators are classified into four groups based on functional
characteristics, structural properties, and cofactor require-
ments (11). Group A and B prothrombin activators are metal-
loproteinases, whereas Group C and D prothrombin activa-
tors are serine proteinases. Some Australian snake venoms
are known to contain Group C or Group D prothrombin acti-
vators (12). Group C prothrombin activators resemble the
mammalian Factor Xa (FXa)1-Factor Va (FVa) complex,
whereas Group D activators are structurally and functionally
similar to FXa alone (12, 13). The Group C prothrombin acti-
vator from the Australian brown snake, P. textilis, has been
extensively studied and named Pseutarin C (14). The 1461-
amino acid FVa-like non-enzymatic subunit of Pseutarin C has
been shown to share 50% sequence identity and significant
structural homology with human FVa (15). Another hemosta-
sis-related family of proteins identified in Australian snake
venom is the textilinin family of plasmin inhibitors (16). These
7-kDa proteins share 45% identity with aprotinin, a bovine
Kunitz-type serine protease inhibitor that acts on plasmin and
kallikrein to reduce blood loss during surgery. Six isoforms of
textilinin have been identified in P. textilis venom gland-de-
rived cDNA (7).
Australian snake venoms are also known to contain PLA2s
and peptidic neurotoxins (for a review, see Ref. 17). Australian
elapid PLA2s have seven conserved disulfide bonds and mo-
lecular masses of 13–15 kDa. As well as phospholipase ac-
tivity, individual PLA2s are known to have myotoxic, neuro-
toxic, and/or anticoagulant activities. The -neurotoxins
found in Australian elapids are postsynaptic blocking short or
long chain neurotoxins (18, 19). Short and long chain neuro-
toxins have similar effects and bind with high affinity to skel-
etal nicotinic acetylcholine receptors. The short chain neuro-
toxins have four disulfide bonds and are 60 amino acids in
length, whereas the long chain neurotoxins have five disulfide
bonds and are 73 amino acids in length. More recently,
neurotoxic cysteine-rich secreted proteins (CRISPs) have
been identified and characterized from the Australian elapids
Pseudechis australis and Pseudechis porphyriacus (20, 21).
These 211-amino acid proteins show the ability to block cyclic
nucleotide-gated ion channels involved in signaling from the
visual and olfactory systems.
Other proteins known to exist in Australian elapid venoms
include L-amino-acid oxidase, nerve growth factor (NGF), and
natriuretic peptides. L-Amino-acid oxidase was identified in P.
australis venom and in purified form was found to be antibac-
terial when tested against the important pathogen Aeromonas
hydrophila (22). This protein has also been identified in Viper-
idae snake venoms. NGF has been identified in multiple Asian
and African snake venoms but has been reported only re-
cently as a component of Australian elapid venoms (23). NGF
from Oxyuranus scutellatus venom is glycosylated and shows
the ability to induce neurite outgrowth of PC12 cells, a stand-
ard assay for NGF activity (23). Natriuretic peptides from
Oxyuranus microlepidotus venom show potent arterial
smooth muscle relaxant effects (24). Natriuretic peptides have
been identified and characterized from several Australian
elapid venoms and represent the smallest known proteins
from these venoms at only 35–39 amino acids (25).
The present study describes a thorough screening and
identification of the venom proteins present in 18 Australian
elapid snake species representing nine genera of the most
venomous snakes on earth. In addition, post-translational
modifications such as glycosylation, phosphorylation, and
-carboxylation were examined in the venom proteins using
specific stains and antibodies. Glycoforms of multiple pro-
teins were identified and characterized using lectin binding
specificity. Also antivenom reactivity of venom proteins was
examined using tiger snake (Notechis) antivenom raised in
horses for clinical use in envenomated people. Many proteins
previously unknown in Australian snake venoms were identi-
fied based on sequence matches to venom proteins from
other snakes. This information sheds light on evolutionary
relationships between the different snake species and the
clinical manifestations of envenomation. This comprehensive
proteomics analysis brings Australian elapid snakes in line
with their well studied American and Asian counterparts and
represents a valuable resource for the future development of
novel human therapeutics.
EXPERIMENTAL PROCEDURES
Materials: Snake Venoms and Chemicals—Venom samples from
the 18 snake species (Table I) were obtained in lyophilized form from
Venom Supplies Pty. Ltd. (Tanunda, South Australia, Australia).
Venom samples were collected over the course of a year and pooled
from at least 10 snakes from each species to reduce seasonal and
individual variation. Lyophilized venom samples were resuspended in
50% glycerol, 50% PBS to a final protein concentration of 10 mg/ml.
Water was prepared using a Milli-Q system (Millipore, Bedford, MA).
FITC-labeled lectins were from Vector Laboratories (Burlingame, CA).
PNGase F and phosphatase (Antarctic phosphatase) were from New
England Biolabs (Beverly, MA). Antiserum to P. textilis Factor Xa-like
heavy chain antisera was raised in sheep against the purified protein
(26). Monoclonal antibody against -carboxyglutamate (Gla) residues
was from American Diagnostica Inc. (Greenwich, CT). Tiger snake
(Notechis scutatus) antivenom was from Commonwealth Serum Lab-
oratories Ltd. (Victoria, Australia). All other chemicals were from
Sigma unless stated otherwise.
Electrophoresis—Prior to the first dimension IEF, 30 l (300 g
total) of reconstituted venom was added to 170 l of rehydration
1 The abbreviations used are: FXa, Factor Xa; FVa, Factor Va; 2D,
two-dimensional; 1D, one-dimensional; Gla, -carboxyglutamate;
PNGase F, peptidyl-N-glycosidase F; ConA, concanavalin A; WGA,
wheat germ agglutinin; RCA120, Ricinus communis agglutinin 120;
GalNAc, N-acetylgalactosamine; GlcNAc, N-acetylglucosamine;
PLA2, phospholipase A2; NGF, nerve growth factor; CRISP, cysteine-
rich secreted protein; PDI, protein-disulfide isomerase; SVMP, snake
venom metalloproteinase; GRP78, glucose-regulated protein 78;
ACTH, adrenocorticotropic hormone; clip, corticotropin-like interme-
diate lobe peptide; PMM, peptide mass mapping; SNA, Sambucus
nigra lectin; UEA, Ulex europaeus agglutinin.
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solution containing 7 M urea, 2 M thiourea, 4% (w/v) CHAPS, 10 mM
DTT, and 0.2% (v/v) pH 3–10 Biolyte ampholytes (Bio-Rad). The final
volume of 200 l was applied to a precast Bio-Rad 11-cm pH 3–10
linear IPG strip. First dimension IEF was carried out in a Bio-Rad
Protean isoelectric focusing unit at 20 °C using a three-phase pro-
gram: 250-V rapid gradient for 15 min, 250–8000-V linear gradient for
3 h, and 8000-V rapid gradient to a total of 40,000 V-h. Prior to the
second dimension, the proteins in the IPG strips were reduced and
alkylated by sequential 15-min incubations in a solution containing
0.05 M Tris-HCl, pH 8.8, 6 M urea, 2% (w/v) SDS, 20% (v/v) glycerol,
and (i) 10 mM DTT in 100 mM ammonium bicarbonate for reduction
and (ii) 55 mM iodoacetamide in 100 mM ammonium bicarbonate for
alkylation. IPG strips were then applied to 12% Tris-HCl acrylamide
gels (Bio-Rad Criterion, 13  10 cm) for second dimension electro-
phoresis at 200 V for 65 min. Gels were stained with a mass spec-
trometry-compatible silver stain based on a method described previ-
ously (27).
Identification of Venom Components and de Novo Sequencing
Using MALDI-TOF Mass Spectrometry—Protein spots from silver-
stained 2D PAGE were excised, washed in water, and destained as
described previously (28). Trypsin was added, and proteins were
allowed to digest overnight at 37 °C prior to extraction. Extracted
peptides were dried; resuspended in 50% ACN, 0.1% TFA; mixed 1:1
with matrix (10 mg/ml -cyano-4-hydroxycinamic acid in 60% ace-
tonitrile, 25 mM ammonium bicarbonate); and spotted on a MALDI
plate. Peptides were analyzed by MALDI-TOF/TOF MS/MS using a
4700 Proteomics Analyzer (Applied Biosystems) operated in positive
ion reflectron mode. MS data were acquired using 2000 shots of a
neodymium-doped yttrium aluminium garnet (Nd:YAG) laser at 355
nm with a 200-Hz repetition rate and fixed intensity. MS data were
calibrated via a plate wide external calibration using the 4700 Mass
Standards kit (Applied Biosystems) containing des-Arg-bradykinin
(MH 904.458), angiotensin I (MH 1296.685), Glu-fibrinopeptide B
(MH 1570.677), ACTH (1–17 clip, MH 2093.087), ACTH (18–39 clip,
MH 2465.199), and ACTH (7–38 clip, MH 3657.929). The top 50
most intense peptides detected for each spot in the MS mode were
automatically selected for MS/MS analysis using 3000 laser shots at
a fixed intensity 20% greater than that used for MS. MS/MS data
were calibrated against the MS/MS fragments of the m/z  1296.685
angiotensin I peptide in the standards. With regard to the MS/MS
analysis, no CID was used. Metastable decay was used exclusively to
obtain fragment ion information without the introduction of CID gas
into source 2. Interference from metastable decay of the precursor
ions postsource 2 was precluded using metastable ion suppression
Alternatively peptides were analyzed using a Microflex MALDI-TOF
PSD instrument (Bruker Daltonics, Bremen, Germany) operated in
positive ion reflectron mode. MS data were acquired using 350 shots
of a nitrogen laser at 355 nm with a 20-Hz repetition rate and varying
intensity. MS data were calibrated via close external calibration using
peptide standards (New England Biolabs) containing angiotensin I
(MH 1296.69), neurotensin (MH 1672.92), ACTH (1–17 clip, MH
2093.09), ACTH (18–39 clip, MH 2465.20), and ACTH (7–38 clip,
MH 3657.93). The top three most intense peptides detected for each
spot in the MS mode were automatically selected for PSD analysis
using 15 segments with 200 shots per segment. Initial laser power
was25% greater than for MS. The segments were stitched together
by Flex Analysis software (Version 2.4, Bruker Daltonics) for sequence
interpretation. PSD data were internally calibrated.
MALDI-TOF/TOF MS/MS data from the 4700 Proteomics Analyzer
were automatically analyzed using the GPS Explorer suite of software
(Version 3.5 Build 321, Applied Biosystems). For each spot a com-
bined MS and MS/MS analysis was performed in-house using a
Mascot search engine (Version 1.9) and the Celera Discovery System
database (CDS Combined KBMS2.1.20030813 containing 1,335,729
sequences, dated May 5, 2006). MS peptide tolerance was 100 ppm,
and MS/MS tolerance was 0.3 Da. MALDI-TOF PSD data from the
Microflex were automatically analyzed using Biotools 3.0 software
(Bruker Daltonics). For each spot MS and PSD data were separately
searched in-house using the Mascot search engine (Version 1.9) and
the Chordata taxonomic subset of the National Center for Biotech-
nology Information non-redundant database (NCBInr 20060111;
Chordata subset; 627,293 sequences; dated January 11, 2006). In
both cases, mass tolerance was set at 150 ppm. All searches took
into account carbamidomethylated cysteine and oxidized methionine.
For the purposes of protein identification, no other post-translational
modifications were considered, and the top matched protein from the
database searches was included in Supplemental Table 1. The scores
used to evaluate the quality of matches for MS/MS data appear in
Supplemental Table 1 in columns titled “Ion Score” and “Ion Score
confidence interval” calculated by the Mascot search engine. Protein
and ion scores increase where the experimental fragmentation data
matches theoretical fragmentation data. With regard to acceptance
criteria for protein identification, those candidates with Mascot scores
greater than the 95% confidence threshold (generally a protein score
of 65) and whose protein mass and pI correlated with the 2D PAGE
spot were automatically accepted. Those candidates with Mascot
scores below the 95% confidence threshold but whose identity
matched to a known snake venom protein were also included. Can-
didates still unknown were selected for de novo peptide sequencing.
For de novo peptide sequencing, MALDI-TOF/TOF MS/MS data
were opened in Data Explorer (Applied Biosystems, Version 4.2) and
deisotoped, and raw text peak lists were exported. The peak lists
were analyzed using the automatic de novo function of PEAKS Studio
software Version 2.4 (29) (Bioinformatics Solutions Inc., Ontario, Can-
ada). Peptide sequences of 6 or more amino acids with a 100%
confidence call using parent ion and fragment mass error tolerances
of 0.1 Da were collected and matched to the NCBI non-redundant
protein database using the protein Basic Local Alignment Search Tool
(BLAST) algorithm (Version 2.2.14, www.ncbi.nlm.nih.gov/BLAST/).
Enzymatic Deglycosylation—Venom samples (50 g) were precip-
itated in 8:1 acetone:methanol for 16 h at 20 °C. Samples were
centrifuged for 30 min at 16000  g and 4 °C to pellet protein. The
supernatants were removed and discarded, and the protein pellets
were allowed to air dry for 10 min under ambient conditions. PNGase
F (New England Biolabs) was subsequently used according to the
manufacturer’s instructions. Reactions were allowed to proceed for
16 h at 37 °C.
Lectin Binding Specificity—Venom samples (100 g) were sepa-
rated by 1D PAGE as described above and transferred onto nitrocel-
lulose membrane in Towbin buffer at 100 V for 1 h. Glycosylation
profiles of the venom proteins were examined using a panel of eight
lectins labeled with FITC (Fluorescein Lectin Kit 1, Vector Laborato-
ries) as described previously (30).
Phosphoprotein and Glycoprotein Staining—Detection of phos-
phoproteins and glycoproteins in 1D PAGE was performed using the
ProQ Diamond and ProQ Emerald fluorescent reagents, respectively
(Molecular Probes, Invitrogen) according to the manufacturer’s in-
structions. ProQ Emerald is a fluorescent form of the periodic acid-
Schiff stain for carbohydrates that has a broad range of specificity for
glycol containing molecules.
Immunoblotting and Antivenom Reactivity—Immunoblotting for Gla
residues and the heavy chain of the FXa-like protease was performed
as described previously (31). Tiger snake antivenom reactivity was
performed similarly to immunoblotting as follows. Proteins were sep-
arated by 1D SDS-PAGE, transferred to nitrocellulose membrane,
blocked in 5% skim milk, and incubated overnight in a 1:2000 dilution
of antivenom in PBS with 0.05% Tween 20. After extensive washing,
the membrane was incubated in a 1:2000 dilution of goat anti-horse
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Ig conjugated to horseradish peroxidase, and signal was detected
using ECL reagent.
RESULTS
Separation and Comparative Analysis of Venom Proteins
from 18 Australian Elapid Snake Species
Protein components of the venoms from the 18 species
listed in Table I were initially separated by 1D SDS-PAGE and
subsequently silver-stained (Fig. 1). A similarity of protein
bands between individual species within a single genus was
apparent. For example, a prominent band of 30–35 kDa cor-
responding in size to the heavy chain of FXa-like protease was
observed in several venoms including the Notechis (lanes
1–3), Pseudonaja (lanes 4–6), and Oxyuranus (lanes 14 and
15) species. In addition, several venoms showed significant
staining of proteins primarily between 13 and 15 kDa, which is
consistent with the size of PLA2 isoforms known to be abun-
dant in elapid snake venoms. Moreover the multiplicity of
bands between 10 and 170 kDa for all species highlights the
complexity of these venoms and necessitated the use of 2D
PAGE to achieve resolution of individual protein isoforms.
The results in Fig. 2 show representative 2D PAGE silver-
stained maps for a single species from all nine genera with
resolution of proteins in the size range of 6–160 kDa over a pI
range of 3–10. Between 100 and 200 individual protein spots
were resolved in the different maps. Horizontal trains of spots
are apparent in the upper region of the 2D PAGE maps
consistent with multiple isoforms of individual proteins. This
phenomenon has been observed previously in 2D PAGE of
venom proteins from other snake species (32, 33). Although
up to 200 spots were resolved on each gel, only a limited
number of protein families appeared to be present. The 2D
PAGE maps for all 18 species without annotation appear in
Supplemental Fig. 1, A-R, and with annotation in Supplemen-
tal Fig. 2, A-R. The mass spectrometry data corresponding to
each identified protein spot appear in Supplemental Table 1.
Comparison of the distinct protein spots on the maps showed
features characteristic of species within the same genera. For
example, comparison of the four Pseudechis species showed
a high degree of similarity between P. australis, Pseudechis
guttatus, and Pseudechis colletti. Although most of the pro-
tein families present in these three species also appear to be
represented in the fourth member of this group, P. porphyria-
cus, it is evident that the protein pI values have a different
pattern of distribution across the range of separation. It is also
notable that P. porphyriacus is the only member of this genus
known to have procoagulant activity, and the data described
here point to additional variation at the protein level (8).
Identification of Proteins by Mass Spectrometry
Approximately 60 spots were selected from 2D PAGE for
each species across a range of molecular sizes and pI values
for further analysis. Gel spots were excised and digested with
trypsin, and peptides were collected for analysis by MALDI-
TOF, MALDI-TOF PSD, and MALDI-TOF/TOF MS/MS. The
mass spectra were matched to the NCBI non-redundant or
Celera databases to identify the protein spots using the Mas-
cot search engine. Spectra for those spots that were not
identified by this approach were subjected to de novo peptide
sequence analysis using the PEAKS software package (Bioin-
formatics Solutions Inc.). The de novo peptide sequences
were used in homology searches using the NCBI protein
TABLE I
Snake venoms investigated
Genus No. Species Common name
Notechis 1 N. scutatus Mainland tiger
(tiger snakes) 2 N. ater niger Revesby Island tiger
3 N. ater serventyi Chappell Island tiger
Pseudonaja 4 P. nuchalis Westerm brown
(brown snakes) 5 P. affinis Dugite
6 P. inframacula Peninsula brown
Austrelaps 7 A. superbus Lowland copperhead
(copperheads) 8 A. ramsayi Highland copperhead
Pseudechis 9 P. porphyriacus Red-bellied black
(black snakes) 10 P. australis King brown
11 P. guttatus Blue-bellied black
12 P. colletti Colletts snake
Acanthophis
(death adder)
13 A. antarcticus Common death adder
Oxyuranus (taipans) 14 O. scutellatus Coastal taipan
15 O. microlepidotus Inland taipan
Tropidechis 16 T. carinatus Rough scale snake
Rhinoplocephalus 17 R. nigrescens Small-eyed snake
Hoplocephalus 18 H. stephensii Stephen’s banded snake
FIG. 1. SDS-PAGE of 18 Australian snake venoms. 100-g sam-
ples of 18 crude venoms from the snakes listed in Table I were
separated by 12% SDS-PAGE and subsequently silver-stained.
Brackets above lanes indicate species of the same genus. Lane 1, N.
scutatus; lane 2, N. ater niger; lane 3, N. ater serventyi; lane 4, P.
nuchalis; lane 5, P. affinis; lane 6, Pseudonaja inframacula; lane 7, A.
superbus; lane 8, Austrelaps ramsayi; lane 9, P. porphyriacus; lane 10,
P. australis; lane 11, P. guttatus; lane 12, P. colletti; lane 13, A.
antarcticus; lane 14, O. scutellatus; lane 15, O. microlepidotus; lane
16, T. carinatus; lane 17, R. nigrescens; lane 18, H. stephensii.
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BLAST facility (www.ncbi.nlm.nih.gov/BLAST/). Using this
combined approach, between 24 and 51 spots for each spe-
cies were confidently identified, representing a total of 17
different protein families (Table II). A number of protein spots
were not identified using the above approach possibly be-
cause the peptide sequences derived were not sufficiently
homologous to those in the sequence databases searched.
A total of 724 protein identifications were made, and a
complete list of these together with their protein and ion
scores appears in Supplemental Table 1. Various combina-
tions of the different protein families were present in the 18
species within the nine genera studied (Table II). Supplemen-
tal Fig. 3 contains annotated fragmentation spectra for those
131 of 724 (18.1%) protein identifications based on a single
peptide. Supplemental Fig. 4 contains annotated MALDI-TOF
spectra for the 34 of 724 (4.7%) protein identifications based
on peptide mass mapping (PMM). In some of the PMM spec-
tra several major peaks were not matched suggesting either
more than one protein in the spot or incomplete homology
with database entries. Although a range of protein and ion
scores were obtained in the mass spectrometry analysis,
overall the data provided a high level of confidence that the
identifications were correct. This was evident by the generally
high protein and ion scores for the PMM and MS/MS data as
well as high levels of sequence homology in the protein
BLAST results from de novo peptide sequencing where the
former approach failed to identify the protein. Identities and
characteristics of the 17 protein families are provided below.
PLA2s and PLA2 Inhibitors—The most frequently encoun-
tered proteins identified across the species were PLA2s that
were found in all 18 venoms. In all cases there were multiple
PLA2 isoforms representing sequence variants. Because of
the large number of isoforms and associated activities for
these proteins, information on the specific PLA2s identified
within the different species can be accessed through the
NCBI accession numbers provided in Supplemental Table 1.
In the majority of cases the PLA2 isoforms were in the molec-
ular size range of 13–17 kDa as predicted from published data
and in some cases their cDNA sequences (34). However, in
other cases (for example Acanthophis, Fig. 2F) there was
considerable size variation with PLA2s ranging from 13 to 30
kDa. Surprisingly we also detected a protein homologous to
the  isoform of PLA2 inhibitor (35) (NCBI accession number
CAB56615) in both Pseudonaja nuchalis and O. microlepido-
tus. This is the first description of a PLA2 inhibitor in the
FIG. 2. 2D SDS-PAGE of crude venom from species representing all nine genera. A–I, 300-g samples of crude venoms representing
nine species of different genera were subjected to isoelectric focusing on 11-cm pH 3–10 IEF strips and subsequently separated by 12%
SDS-PAGE and silver-stained. Protein spots were excised for identification by MALDI-TOF/TOF MS/MS, MALDI-TOF PSD, and de novo
peptide sequencing. Complete data are contained in Supplemental Figs. 1 and 2 and Supplemental Table 1.
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venom of any snake. Previous reports have demonstrated that
PLA2 inhibitors are present in the blood of Elapidae, Hy-
drophidae, Boidae, and Colubridae genera, and it was as-
sumed that they were present to provide protection against
any PLA2s appearing inadvertently in the blood (for a review,
see Ref. 36).
Neurotoxins and Protease Inhibitors—Australian snake ven-
oms are known to contain a multitude of neurotoxins including
short and long chain -neurotoxins and neurotoxic PLA2s (8).
Long chain neurotoxins were found in the majority of venoms.
These were readily identifiable in all species of Notechis and
Pseudonaja but only in one (P. australis) of the Pseudechis
species. On the other hand, short chain neurotoxins were only
detected in three species (Table II). The Kunitz-type serine
protease inhibitor textilinin was identified in all species of the
Pseudonaja genus as expected. We have previously identified
multiple forms of textilinin both at the protein and cDNA level
in P. textilis (7, 16). Proteins with homology to textilinin were
also found in the Notechis, Acanthophis, Pseudechis, Tropi-
dechis, and Oxyuranus genera. This molecule is an antifibrino-
lytic agent that inhibits plasmin (7).
Prothrombin Activators—Another snake protein known to
affect hemostasis is the FXa-like prothrombin activator previ-
ously identified in Pseudonaja and other genera (37). The
heavy chain of this protein was identified in all the Notechis,
Oxyuranus, and Pseudonaja species along with Tropidechis
carinatus, Hoplocephalus stephensii, Rhinoplocephalus nigre-
scens, and P. porphyriacus. This is consistent with the pres-
ence of procoagulant activity in all of these snakes (8). The
heavy chain was identified as a train of spots at 35 kDa and
with pI generally ranging from 6 to 9. This peptide was not
found in the Austrelaps or other three Pseudechis species or
in Acanthophis antarcticus. This is in accordance with previ-
ous data showing that these snakes possess largely antico-
agulant venoms (8). In addition, the light chain of the FXa-like
molecule is known to contain Gla residues, and immunoblot-
ting with Gla-specific antibody (Fig. 3A) showed reactivity only
to species where the heavy chain was also identified by 2D
PAGE and MS. It is also notable that the light chain was only
identified by mass spectrometry in three species. This is in
agreement with previous data where it has been difficult to
detect the presence of this peptide by both Coomassie Blue
and silver staining (31). The non-enzymatic cofactor of the
prothrombin activator, FVa-like protein, was identified only in
Pseudonaja and Oxyuranus, the only two genera known to
contain a complete prothrombin activator (15, 37).
Vespryns—Using MS-based peptide sequencing we iden-
tified two peptides in a T. carinatus 2D PAGE protein spot
(Supplemental Fig. 2P, spot 14) that showed homology to
Ohanin, recently described for the first time in Ophiophagus
hannah (king cobra) venom (38). Ohanin is the first of a new
family of proteins named as vespryns. The peptides identified
in T. carinatus covered 21 of the 109 residues (19%) of the
mature O. hannah protein, and both peptides were located
near the center of the protein. Primers were designed based
on the full-length O. hannah mRNA sequence (NCBI acces-
TABLE II
Protein families identified in the 18 snake venoms
Neuro, neurotoxin; Kunitz, Kunitz-like serine protease inhibitor; Inhib, inhibitor; LAAO, L-amino-acid oxidase; AChE, acetylcholinesterase;
5Nuc, 5-nucleotidase.
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sion number AY351433) and were used to amplify the full-
length cDNA from venom gland RNA from T. carinatus and
several of the other species.2 The presence of RNA transcripts
in elapid venom glands other than T. carinatus suggests the
presence of the protein in these venoms; however, no other
protein spots in any of the other 17 venoms were identified as
vespryns.
Metalloproteinases—In the higher molecular size region,
seven of the 18 2D PAGE maps (39%), proteins were matched
via MS to proteins homologous to snake venom metallopro-
teinases (SVMPs). These proteins have been observed in
abundance in venoms of viper snakes and also in some
elapids (39, 40). The peptides observed identified the Austra-
lian elapid metalloproteinases as PIII type SVMPs that contain
a reprolysin zinc metalloprotease domain, a disintegrin do-
main, and a C-terminal cysteine-rich domain.
C-type Lectins—Protein spots of 15 kDa from six of the
2D PAGE maps were matched via MS to a C-type lectin from
Bungarussp.venom.C-typelectinsarenon-enzymatic,calcium-
dependent, sugar-binding proteins and have been identified
previously in several Viperidae and a limited number of Elap-
idae venoms.
Other Protein Families—Acetylcholinesterase, NGF, 5-nu-
cleotidase, CRISP, L-amino-acid oxidase, protein-disulfide
isomerase, and glucose-regulated protein 78 (GRP78) were
also isolated in 2D PAGE maps of some of the venoms.
Acetylcholinesterase has been characterized previously from
Bungarus fasciatus venom (41) and in this study matched to a
70-kDa series of spots spanning2 pI units in five venoms (A.
antarcticus, Notechis ater niger, N. scutatus, Austrelaps su-
perbus, and P. australis). NGF has been identified recently as
a component of six Australian elapid venoms (23) and in this
study was identified in a further six snakes. 5-Nucleotidase
activity has been demonstrated in a variety of snake venoms,
including the Australian elapids (42). In support of these data,
protein spots matching to mammalian 5-nucleotidase were
observed in seven different venoms including the Oxyuranus
species. 2D gel spots corresponding to CRISPs were identi-
fied in four venoms. L-Amino-acid oxidase has been identified
previously in P. australis venom and in this study was identi-
fied in 12 Australian elapid venoms, including P. australis.
Protein-disulfide isomerase was identified in P. nuchalis
(Western brown snake). Two discrete spots of 50 kDa in the
PAGE separation of the venom of Notechis ater serventyi
(Supplemental Fig. 2C, spots 19 and 38) were matched via
MS to GRP78. This protein has also been identified recently in
the venom of another Australian elapid, P. textilis (31).
Post-translational Modification of Venom Proteins
We have shown previously that 2D PAGE separation of P.
textilis venom proteins gives rise to multiple horizontal trains
of spots for several proteins, representing differing numbers
of charged groups attached post-translationally (31). This
phenomenon was evident in the 2D maps for all 18 species of
snake venoms in the current study. A clear example of this
was observed for the heavy chain of FXa-like protease (35
kDa) present in the three Notechis species (Supplemental Fig.
1, A–C), the three Pseudonaja species (Supplemental Fig. 1,
D–F), P. porphyriacus (Supplemental Fig. 1K), and the two
Oxyuranus species (Supplemental Fig. 1, N and O). In N.
scutatus, this heavy chain was observed as spots ranging in pI
from 8 to 10 (Supplemental Fig. 2A, spots 26–28), whereas
the predicted pI from the cDNA sequence (NCBI accession
number AAX37262) is 8.7. This suggests modifications are
added to the heavy chain isoforms resulting in both loss and
gain of charge with only minor influence on molecular size.
2 G. W. Birrell, S. T. H. Earl, P. P. Masci, J. de Jersey, and M. F.
Lavin, manuscript in preparation.
FIG. 3. Post-translational modifications observed in the 18 ven-
oms. A, 100 g of crude venoms were separated by 12% SDS-PAGE,
transferred to nitrocellulose, and immunoblotted using antibody to
Gla residues. B and C, 100 g of crude venoms were separated by
12% SDS-PAGE, and the gels were subsequently stained with ProQ
Diamond phosphoprotein-specific stain (B) or with ProQ Emerald
glycoprotein-specific stain (C).
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Virtually all the proteins above 30 kDa in all 18 species were
represented by multiple horizontal trains of spots.
Although a number of different post-translational modifica-
tions have been reported for snake venom proteins (33), no
evidence has been presented for changes in phosphorylation
status. Mammalian FVa has been shown to be phosphoryla-
ted on Ser-692, which may be important for its inactivation by
activated protein C (43). This site is not present in the FVa-like
molecule from P. textilis, but Rao et al. (15) have described
several predicted phosphorylation sites in this molecule. In an
effort to establish the phosphorylation status of venom pro-
teins in all 18 species we used the ProQ Diamond stain, which
has been reported to be specific for phosphoproteins (44).
The results in Fig. 3B reveal the presence of strongly staining
phosphorylated proteins over a wide range of molecular sizes
in seven of the nine genera studied. Acanthophis and Oxyura-
nus displayed only low intensity staining. Curiously there was
a wide range of staining intensity of protein bands within
genera as clearly demonstrated by the variation among the
three Notechis species (Fig. 3B, lanes 1–3). The lack of signal
in the case of N. ater niger (Fig. 3B, lane 2) is not due to lower
protein loading as the same amount of protein was used as in
Fig. 1 where the silver-stained gel shows equal loading. No
phosphorylation was detected for FXa-like protease heavy
and light chains, which are present in abundance in Notechis,
Pseudonaja, Oxyuranus, and other species. The identity of
these phosphorylated proteins remains to be determined.
Glycoproteins were also detected using the specific stain
ProQ Emerald (Fig. 3C). Glycosylation of a high molecular
weight region corresponding in size to the FVa-like protein
was particularly prominent for all three Pseudonaja species.
Some labeling was also seen for the Oxyuranus species,
which also contain Factor Va-like protein. As expected, nei-
ther the Notechis, P. porphyriacus, T. carinatus, R. nigrescens,
nor H. stephensii had evidence of glycosylation in the high
molecular weight region. Although all of these have prothrom-
binase activity and possess an FXa-like protease they do not
have the FVa molecule.
The rather extensive amount of phosphorylation observed
in the Notechis and other species such as T. carinatus could
mean direct phosphorylation of serine, threonine, and/or ty-
rosine residues on the protein or the presence of phospho-
rylated glycan groups on glycoproteins. Accordingly we
treated crude venom from these snakes with either deglyco-
sylase (PNGase F) or phosphatase. A Coomassie-stained gel
showed that deglycosylation significantly altered the pattern
of protein migration (Fig. 4A, lanes 2, 5, 8, and 11), whereas
phosphatase treatment (lanes 3, 6, 9, and 12) showed no
discernible effect. Staining for phosphorylated proteins with
ProQ Diamond revealed the same degree of loss of phos-
phate groups after treatment with either deglycosylase or
phosphatase (Fig. 4B), suggesting that the phosphate groups
were attached to the glycans rather than directly to the pro-
tein. The prominent band at 35 kDa lost its ProQ Diamond
reactivity for both N. scutatus and N. ater serventyi crude
venoms after treatment with deglycosylase and phosphatase
(Fig. 4B, arrow). We demonstrated that this band corresponds
to the heavy chain of the FXa-like molecule by immunoblotting
and showed that glycosidase treatment generated two dis-
crete bands, one corresponding to the native protein (30 kDa)
and a second band (27 kDa) corresponding to the calculated
mass of the native protein (Fig. 4C). The existence of the
upper 30-kDa band suggests incomplete deglycosylation. Al-
though only two species of the FXa-like protease heavy chain
were detected on the 1D gels, up to seven discrete spots
corresponding to this protein were resolved by 2D PAGE.
Immunoblotting with an antivenom against N. scutatus venom
also detected these two bands in a region corresponding to
the FXa-like heavy chain (Fig. 4D). There was also evidence of
cleavage of additional proteins of higher molecular size. It is of
interest that this antivenom also detected a similar distribution
and cleavage pattern of proteins in the other two Notechis
species as well as T. carinatus (Fig. 4D). The strong reactivity
of the antivenom in the low molecular size region correspond-
ing to neurotoxins is consistent with the reported ability of this
antivenom to neutralize neurotoxin activity (45).
We have shown previously that fluorescently labeled lectins
detect a variety of glycoprotein moieties in venom proteins
from P. textilis (31). Using similar methodology, we studied the
binding of eight different lectins to proteins separated from all
18 venoms by 1D SDS-PAGE (Fig. 5). Wheat germ agglutinin
(WGA), which binds to N-acetylglucosamine (GlcNAc) and
sialic acid, detected a protein band of 13–15 kDa correspond-
ing to the abundant PLA2s (Fig. 5A) in most species except for
T. carinatus, R. nigrescens, H. stephensii, and one of the three
Pseudonaja species, Pseudonaja affinis. This is consistent
with an earlier report showing GlcNAc attached to a PLA2
from O. scutellatus (46). There was very prominent staining of
a protein of lower molecular size corresponding to the Kunitz-
like serine protease inhibitors in three of the 18 species, two of
the three Pseudonaja (again not evident in P. affinis) and A.
antarcticus. A similar pattern of staining in this molecular size
region was also evident in the same species using ConA
(mannose and glucose), SNA (sialic acid), Dolichos biflorus
agglutinin (N-acetylgalactosamine), UEA (fucose), soybean
agglutinin (N-acetylgalactosamine and galactose), RCA120
(N-acetylgalactosamine and galactose), and peanut agglutinin
(galactose) binding. However in the case of ConA binding,
more prominent labeling was observed for T. carinatus, R.
nigrescens, and H. stephensii. A prominent binding band at
22 kDa was detected by SNA and UEA (Fig. 5, C and E) that
detect sialic acid or one of its constituents. Although this band
is in a region corresponding to the light chain of the FXa-like
protease, it is unlikely that this protein has been modified
because it was detected in several species that do not have a
prothrombin activator. Lectin binding in the high molecular
weight region was prominent for WGA and ConA for the vast
majority of the 18 species, whereas very little reactivity was
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seen in this region for the other six lectins. However, there
was some reactivity seen with RCA120 (N-acetylgalac-
tosamine and galactose) in a few species.
DISCUSSION
This study represents the first thorough proteomics study of
the venoms from the major species of Australian elapid
snakes. In all, we identified members of 17 different protein
families in nine different genera. The relative lack of complex-
ity allowed us via MS to identify the majority of the proteins
separated by 2D PAGE. Proteins were isolated with isoelectric
points from 3 to 10 and with molecular sizes ranging from 5 up
to 160 kDa. It was evident that there were conserved patterns
of protein staining within genera. The most obvious example
of this was for the prothrombin activator, which is present in
Notechis, Pseudonaja, Oxyuranus, only one of the Pseudechis
species, T. carinatus, R. nigrescens, and H. stephensii. Co-
agulopathy is thought to represent the major cause of mor-
bidity in individuals envenomated by these snakes (8). In the
case of Pseudonaja, all three species had bands that corre-
sponded to components of the prothrombin activator: FVa-
like protein (at 160 kDa), the heavy chain of FXa-like protein (at
35 kDa), and the light chain of the FXa-like protein (at 24 kDa).
This was verified by both mass spectrometry and use of
specific antisera. These proteins were also evident in the two
Oxyuranus species but were present in lesser amount than in
the Pseudonaja species as observed previously (47). St Pierre
et al. (47) used comparative analysis of cDNA clones to reveal
a three-way identity of 91% at the amino acid level of FXa-like
protein between the two Oxyuranus species and P. textilis. In
P. textilis, the prothrombin activator (complex of FXa-like and
FVa-like) represents up to 30% of the dry weight of the venom
(6). Although the Notechis species also contain procoagulant
activity, the FVa-like, non-enzymatic component of the acti-
vator is absent. However, the amount of the FXa-like protease
in these species was similar to that observed in Pseudonaja.
FIG. 4. Effect of deglycosylation and dephosphorylation. Venom samples from four species were treated with glycosidase and phos-
phatase and separated by 12% SDS-PAGE. A, Coomassie-stained gel. Lane 1, N. scutatus venom; lane 2, deglycosylated N. scutatus venom;
lane 3, dephosphorylated N. scutatus venom; lane 4, N. ater niger venom; lane 5, deglycosylated N. ater niger venom; lane 6, dephosphorylated
N. ater niger venom; lane 7, N. ater serventyi venom; lane 8, deglycosylated N. ater serventyi venom; lane 9, dephosphorylated N. ater serventyi
venom; lane 10, T. carinatus venom; lane 11, deglycosylated T. carinatus venom; lane 12, dephosphorylated T. carinatus venom. B, samples
from A run on a parallel gel and stained with ProQ Diamond phosphoprotein-specific stain. C, samples from A run on a parallel gel and
immunoblotted with antiserum to P. textilis Factor Xa-like heavy chain. D, samples from A run on a parallel gel and immunoblotted with
antivenom to N. scutatus. The band marked with an arrow in A and B, lanes 3, 6, 9, and 12, is the Antarctic phosphatase.
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The size difference between this protein band between the
two genera can be explained by the presence of an additional
14 amino acids in the Pseudonaja species (47).
Using mass spectrometry, we identified multiple isoforms of
PLA2s in all of the Australian elapid venoms. Snake venom
PLA2s have been implicated in a number of physiological
processes including hemorrhage, myotoxicity, hemolytic and
hypotensive activities as well as edema, platelet aggregation,
cardiotoxicity, and pre- and postsynaptic neurotoxicity (48).
These proteins have been identified in almost all snake ven-
oms, regardless of genera, and it is the PLA2 enzymes of the
Australian elapids that constitute the single most widely stud-
ied family of toxins from these snakes (49). Consequently
protein sequence data for these enzymes is readily accessible
for PMM matching. Multiple protein spots corresponding to
these enzymes were detected across the entire pI range of
3–10 and generally in the molecular size region of 13–15 kDa.
Previous evidence from Australian elapids, including P. aust-
ralis, N. scutatus, and A. superbus, indicates that there are
multiple PLA2 isoforms within the venom of these snakes (50,
51). A more recent study using cDNA cloning in O. scutellatus
identified eight clones coding for PLA2 sequence variants with
predicted mature protein sizes ranging from 13.3 to 14.4 kDa
and ranging in pI values from 4.6 to 8.4 (34), whereas in the
present study, PLA2s ranged in size from 13 to 50 kDa and in
pI values from 3 to 10.
The PMM and MS/MS data obtained here (Supplemental
Table 1) represents a large number of individual peptides that
correspond to a variety of individual PLA2s, consistent with
previous data that provide evidence for multiple variants of
these enzymes (46). A number of larger molecular size spots
from 2D PAGE also contained PLA2 peptides. However this
may be due to incomplete dissociation of molecular com-
plexes during the 2D PAGE procedure, the existence of novel
higher molecular size forms, and/or post-translational modi-
fications such as glycosylation as suggested by the lectin
binding experiments (Fig. 5). An example of this is the
Taipoxin complex, a potently active toxin complex within the
venom of O. scutellatus composed of three PLA2 chains: , ,
and a glycosylated -chain (46). The -chain has a predicted
molecular size of 14.6 kDa (Swiss-Prot accession number
P00616) yet it migrates to25 kDa on 2D PAGE (Supplemen-
tal Fig. 2, spots 1 and 2) likely due to the existence of N-linked
carbohydrate structure (46). The -chain has been observed
previously to migrate at 26.9 kDa and has a predicted pI of
4.1, which is consistent with that observed on the 2D PAGE
(Supplemental Fig. 2N, spots 1 and 2). Natriuretic peptides
were the only known protein family not found in the present
study possibly due to their small molecular size (35–39 amino
acids) (25).
Novel Snake Venom Proteins—In this study we identified
two novel proteins, protein-disulfide isomerase (PDI) and a
PLA2 inhibitor not previously reported in the venom of any
snake. PDIs are multidomain, multifunctional members of the
thioredoxin superfamily that catalyze thiol oxidation, disulfide
reduction, and isomerization (52). Isomerization occurs di-
rectly by intramolecular disulfide rearrangement or through
cycles of reduction and oxidation (53). Twelve peptides cor-
responding to a PDI sequence in the NCBI protein database
were identified in a protein spot from P. nuchalis whose mo-
lecular size corresponds with the predicted size of the mature
FIG. 5. Lectin binding. Venom proteins were separated by 2D PAGE, and proteins were transferred to nitrocellulose membrane to examine
binding of various lectins. Lane 1, N. scutatus; lane 2, N. ater niger; lane 3, N. ater serventyi; lane 4, P. nuchalis; lane 5, P. affinis; lane 6, P.
inframacula; lane 7, A. superbus; lane 8, A. ramsayi; lane 9, P. porphyriacus; lane 10, P. australis; lane 11, P. guttatus; lane 12, P. colletti; lane
13, A. antarcticus; lane 14, O. scutellatus; lane 15, O. microlepidotus; lane 16, T. carinatus; lane 17, R. nigrescens; lane 18, H. stephensii. A,
WGA (sialic acid and GlcNAc); B, ConA (mannose and glucose); C, SNA (2–3 sialic acid); D, D. biflorus agglutinin (DBA) (GalNAc); E, UEA
(fucose); F, soybean agglutinin (SBA) (GalNAc and galactose); G, RCA120 (GalNAc and galactose); H, peanut agglutinin (PNA) (galactose)
(Lectin binding specificities are shown in parentheses.).
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protein (58 kDa). The database sequence represents a con-
ceptual translation of a cDNA sequence isolated from the
venom gland of O. scutellatus (NCBI accession number
AAY33972) and has not yet been published.3 Because several
of the toxic components of the venom are known to contain
essential disulfide bridges (e.g. PLA2s, textilinins, and pro-
thrombin activator components), it is possible that PDI plays
a role in the synthesis and maintenance of these proteins in
their active structures in the venom gland. Interestingly human
protein-disulfide isomerase has been shown recently to sup-
press tissue factor coagulant activity by targeting a disulfide
bond in tissue factor that is critical for its coagulation activity
(54). This suggests that protein-disulfide isomerase could also
play a role as an anticoagulant in the venom.
The second protein, PLA2 inhibitor, has not been described
in snake venom, but there are several reports of the existence
of such an inhibitor in the blood of American, Asian, and
Australian snakes (35, 55). Hains and Broady (35) purified and
characterized PLA2 inhibitors from the sera of N. scutatus, N.
ater niger, N. ater serventyi, O. scutellatus, O. microlepidotus,
and P. textilis. They proposed that PLA2 inhibitors exist in
snake blood as a defense mechanism against the toxic PLA2
enzymes produced in the venom glands. We were therefore
surprised to find the protein in the venom of P. nuchalis. Three
spots were identified corresponding to two forms of the
-chain and one of the -chain suggesting that it is closely
related, if not identical, to the serum inhibitor. It is not imme-
diately clear why a PLA2 inhibitor would be present in the
venom particularly in such low abundance compared with
PLA2s themselves. However, because not all snake venom
PLA2 enzymes have PLA2 activity, it is possible that the in-
hibitor is specific for only a subclass that could damage the
epithelial lining of the venom gland where they are produced.
It would seem unlikely that the PLA2 inhibitor that we identi-
fied was the result of serum contamination of the venom
sample as no other serum proteins were detected in this or
any other venom sample.
Novel Proteins in Australian Snake Venoms—Four families
of proteins (vespryn, metalloproteinase, C-type lectin, and
acetylcholinesterase) that have been detected previously in
snake venoms from other regions are reported here for the
first time in venoms of Australian elapids. Pung et al. (38) first
described Ohanin as a novel protein from O. hannah (king
cobra) venom and subsequently named this protein subfamily
“vespryns” (56). They cloned a full-length cDNA for this pro-
tein of 1558 bp. The predicted protein contained a propeptide
of 22 amino acids at the N terminus and an additional
“propeptide” of 63 amino acids at the C terminus. The mature
protein was 107 amino acids in length. It was not clear from
the report of Pung et al. (56) how the C-terminal region was
identified as a propeptide. Ohanins are related in sequence to
PRY-SPRY (B30.2-like) domain-containing proteins that in-
clude mammalian ryanodine receptor subtypes and the dual
specificity kinase, splA, found in Dictyostelium discoideum.
There are only three protein sequences in the public domain
with 50% shared identity to Ohanin. These related proteins
are Thaicobrin from Naja kaouthia (UniProt accession number
P82885), an Ohanin-like protein from Lachesis muta (Gen-
BankTM accession number DQ396476), and vespryn-POGU1
from the Australian bearded dragon, Pogona barbata (Gen-
Bank accession number AAZ75637) (57). Indeed Fry et al. (57)
used cDNA libraries and phylogenetic analysis of transcripts
such as vespryn-POGU1 to show that nine toxin types are
shared between lizards and snakes, supporting their theory
for a single, early origin of the venom system in lizards and
snakes.
SVMPs have been identified in some viperid and elapid
venoms and are reported to play key roles in the development
of such symptoms as hemorrhage, edema, hypotension, hy-
povolemia, inflammation, and necrosis (39). SVMPs were
found in seven of the 18 species examined here. The molec-
ular size varied from 60 to 80 kDa with pI in the range of 4–6.
The mass spectrometry data matched to snake venom met-
alloproteinases from the M12B reprolysin subfamily. This sub-
family possesses three different domains: the reprolysin cat-
alytic domain, a disintegrin domain that inhibits the binding of
ligands to integrin receptors, and a cysteine-rich domain. The
peptide sequences identified here were found to match these
regions. It is likely that these enzymes are present in most
Australian elapid snakes because it was possible to success-
fully amplify metalloproteinase cDNAs using PCR primers de-
signed from the cobra cDNA sequence (GenBank accession
number AY101383)4 from seven different genera.2 The pres-
ence of these enzymes in a wide variety of snakes suggests
that they play important roles in toxicity. SVMPs possess
multidomain functions, and it has been shown that the cata-
lytic site is not the only crucial domain enabling this class of
toxin to cause hemorrhage and inflammation (58). This is
evidenced by a form of SVMP, jararhagin C, that lacks the
catalytic domain yet is capable of activating an acute inflam-
matory response in a mouse model (58). Platelets are the main
target of these enzymes in the disruption of hemostasis that
occurs by inhibition of interaction with collagen and/or von
Willebrand factor using various mechanisms that result in
systemic bleeding.
C-type lectins were also identified in Australian elapid
snake venoms for the first time. These calcium-dependent
sugar-binding proteins have been characterized extensively
from Viperidae venoms. However, only a limited number of
C-lectins have been identified in Elapidae venoms, and these
remain to be fully characterized. Viper venom C-lectins have
been shown to cause edema and increased vascular perme-
ability and to agglutinate erythrocytes (59, 60). The C-lectins
identified from the Australian elapids match most closely to a
3 R. E. Welton and J. N. Burnell, unpublished data. 4 D. Sako and G. D. Shaw, unpublished data.
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galactose-binding C-lectin sequence from the krait B. fascia-
tus, suggesting that they also bind this sugar. Although this
protein was only identified in six of the 18 species, C-lectin
cDNAs have been successfully amplified from seven different
genera of Australian elapids5 suggesting that this protein is a
common venom component in these snakes.
Acetylcholinesterase activity has been reported in several
snake venoms previously; however, only one snake venom
acetylcholinesterase has been isolated and characterized,
that from B. fasciatus (41). Acetylcholinesterase was identified
via MS in five species as an 80-kDa train of spots. This
molecular size is consistent with that of B. fasciatus acetyl-
cholinesterase, which is known to contain N-linked glycosy-
lation. Glycosylation of the Australian forms may account for
the train of spots observed in this study.
Post-translational Modifications—We have provided evi-
dence here for at least three types of post-translational mod-
ification in the venom proteins from the different genera of the
Australian elapids: phosphorylation, glycosylation, and -car-
boxylation. Only one previous report, from our laboratory, has
provided evidence for the presence of phosphorylated snake
venom proteins (31). It seems unlikely that this was artifactual
binding because the phosphorylated spots correlated well
with protein staining, and the ProQ Diamond technique has
been shown to be very specific for protein phosphorylation
(44). This method of staining failed to detect phosphate in
DNA or RNA and did not detect sulfated glycans. Birrell et al.
(31) demonstrated that ProQ Diamond detected proteins in P.
textilis that corresponded in size to the major toxins in that
venom including FVa-like and FXa-like proteins as well as
PLA2s. In this study, phosphorylated proteins were detected
in most snake species, and they varied in molecular size from
15 kDa up to greater than 100 kDa. Proteins are normally
phosphorylated as parts of signaling mechanisms, leading to
alterations in their conformation and/or their capacity to inter-
act with other proteins. In this case it is more likely that the
phosphorylated species detected are glycoproteins contain-
ing phosphorylated carbohydrate. Phosphorylated glycopro-
teins are widely distributed in nature and play key roles in a
variety of biological processes. For example, soluble lysoso-
mal proteins are synthesized in the endoplasmic reticulum
and are cotranslationally glycosylated on specific asparagine
residues. As these proteins move through the secretory path-
way, they are selectively recognized by a phosphotransferase
that initiates a two-step reaction that results in the generation
of the mannose 6-phosphate modification on specific
N-linked oligosaccharides. This modification causes the lyso-
somal protein to bind mannose 6-phosphate receptors as part
of the process of endocytosis and lysosomal targeting (61).
Another example of a glycoprotein in which the carbohydrate
moiety is phosphorylated is cathepsin D (62). Cathepsin D is
an aspartic peptidase that is found at elevated levels in some
tumor tissues; however, the role of the phosphorylated car-
bohydrate is unknown. To understand the role of putative
phosphorylated glycoproteins in snake venom it will be nec-
essary to identify these proteins, determine whether phospho-
rylation status influences their interaction with other proteins,
and determine whether phosphorylation alters the function of
these proteins in specific functional assays, e.g. proteolytic
activity, coagulability, or neurotoxicity.
Glycosylation of proteins was detected using lectin binding
and ProQ Emerald staining. A high molecular weight signal
was detected in the venom from several species that corre-
sponded to FVa-like protein in 1D SDS-PAGE (Fig. 3C). This is
in good agreement with previous results using 2D PAGE with
P. textilis that detected spots of the same molecular size as
FVa-like and FXa-like proteins. This was confirmed with ConA
(glucose- and mannose-specific) and WGA (GlcNAc- and
sialic acid-specific) lectins. It is not evident what role this
modification may have on components of the prothrombin
activator, but it is possible that the abundance of glycosyla-
tion of these proteins influences their stability and/or function.
Increased stability would result in greater diffusion and trans-
port of glycosylated toxins upon envenomation.
Clinical Implications—In general, the results of this study
support previous clinical data from patients envenomated by
Australian elapid species. The major clinical effects of Austra-
lian elapid venoms include paralysis, coagulopathy, and mus-
cle destruction, and these symptoms can be attributed largely
to three groups of proteins, neurotoxins, prothrombin activa-
tors, and PLA2s (8). Inspection of the 2D maps showed that
these three groups of proteins account for a large proportion
of the total venom proteins, confirming their high abundance.
We identified several venom proteins not known previously in
Australian snake venoms, but reported in other snake ven-
oms, that may have clinical manifestations. For example,
SVMPs from several Viperidae venoms can cause hemor-
rhage, edema, hypotension, hypovolemia, inflammation, and
necrosis (39). Similarly C-type lectins that have also been
characterized from Viperidae venoms can cause edema and
increased vascular permeability and can agglutinate erythro-
cytes (59, 60). Thus it may be possible that some clinical
effects attributed previously to PLA2s, such as necrosis and
inflammation, are in fact caused by the SVMPs. The clinical
effects of other proteins identified in Australian elapid snakes
for the first time here also remain to be determined. Moreover
some of these proteins may have unique activities applicable
to the development of new human therapeutics.
Conclusions—We have described here a comprehensive
analysis of the venom proteins of 18 Australian elapid snakes
that are among the most venomous snakes worldwide. This
represents a significant advance in the proteomics of snake
venom proteins and an important resource for comparison of
protein patterns both between species of the same genera
and across genera. The vast majority of these proteins were
5 S. T. H. Earl, G. W. Birrell, P. P. Masci, J. de Jersey, and M. F.
Lavin, manuscript in preparation.
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identified using mass spectrometry of spots isolated from 2D
PAGE.
Because a significant number of the peptides isolated failed
to match with any peptides in the NCBI non-redundant pro-
tein database it was necessary to use de novo peptide se-
quencing by tandem mass spectrometry, which significantly
increased the total number of proteins identified. In all, we
identified six previously undescribed families of proteins in
Australian elapid snakes. Some of these, including vespryns,
metalloproteinases, C-type lectins, and 5-nucleotidase were
described previously in non-Australian snake venoms (38,
63–66). Protein-disulfide isomerase and PLA2 inhibitor have
not been reported previously in any snake venom, although a
very recent report has described a cDNA coding for PDI (67),
and a PLA2 inhibitor has been reported in snake serum (36). In
addition to identifying all the major venom proteins in the
Australian snakes, we partially characterized them using spe-
cific antibodies, phosphoprotein- and glycoprotein-specific
stains, enzymatic digestion, lectin binding, and antivenom
reactivity. Further characterization of these proteins will assist
in delineating their role in the venoms, their clinical effects,
and their potential as therapeutic agents.
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